Driehaus Capital Management LLC
Position in GPCR — Structure Therapeutics Inc.
CIK 938206
Chicago, IL
Position in GPCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$76,028,559
-$38,203,421 QoQ
Shares Held
1,577,356
-4.0% QoQ
Ownership
0.740%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Derivatives in GPCR
reported options exposure · as of Dec 31, 2023CallValue
$0
CallShares
0
PutValue
$6,440,080
PutShares
158,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Driehaus Capital Management LLC holds $3,010,622,183 across 56 Biotechnology names. GPCR ranks #13 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
949,225 | $305,830,802 | |
| 2 | XENE |
Xenon Pharmaceuticals Inc.
|
4,491,653 | $261,189,621 | |
| 3 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
6,395,922 | $232,299,887 | |
| 4 | APGE |
Apogee Therapeutics, Inc.
|
1,920,800 | $161,673,736 | |
| 5 | EWTX |
Edgewise Therapeutics, Inc.
|
4,477,942 | $141,055,173 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
2,790,785 | $140,767,195 | |
| 7 | DFTX |
Definium Therapeutics, Inc.
|
5,911,889 | $111,734,702 | |
| 8 | SEPN |
Septerna, Inc.
|
4,395,572 | $105,625,595 |
All Filings in GPCR
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $76,028,559 | 1,577,356 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $114,231,980 | 1,642,444 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $24,458,112 | 873,504 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,953,706 | 672,792 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $22,031,181 | 1,272,743 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $55,796,959 | 2,057,410 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $110,885,012 | 2,526,430 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $101,204,130 | 2,577,136 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $106,734,386 | 2,490,303 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $6,440,080 | 158,000 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $105,938,460 | 2,599,079 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $120,447,127 | 2,388,876 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $47,220,859 | 1,135,936 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $22,368,024 | 940,228 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||